Background Dravet syndrome (DS) is a severe epileptic encephalopathy mainly caused by
haploinsufficiency of the gene SCN1A, which encodes the voltage-gated sodium channel …

Objective To evaluate whether fenfluramine (FFA) is associated with improvement in
everyday executive function (EF)—self-regulation—in preschool-aged children with Dravet …

ABSTRACT Introduction Developmental and Epileptic Encephalopathies (DEEs)
encompass a group of neurological disorders caused by either abnormal neuronal …

Dravet syndrome (DS) is a rare developmental and epileptic encephalopathy. Infants with
DS are especially vulnerable to the detrimental effects of prolonged and frequent seizures …

Aim This cohort study aimed to describe functional mobility in Dravet syndrome, a
developmental and epileptic encephalopathy. Method Functional mobility was assessed in …

Objective Dravet syndrome (DS) is a developmental and epileptic encephalopathy
characterized by high seizure burden, treatment‐resistant epilepsy, and developmental …

The overlap between motor and cognitive signs resulting from posterior parietal cortex
(PPC) and cerebellar lesions can mask their relative contribution in the sensorimotor …

Dravet syndrome (DS) is a rare and severe form of genetic epilepsy characterized by
cognitive and behavioural impairments and progressive gait deterioration. The …

Dravet syndrome (DS) is a severe neurodevelopmental disorder largely due to
heterozygous pathogenic variants in SCN1A encoding the voltage-gated sodium channel α …

Dravet syndrome is a rare developmental epileptic encephalopathy starting in infancy 1. A
mutation in the voltage-gated sodium channel alpha subunit 1 (SCN1A) gene is reported in …